Recent Articles
Here Comes the Big Money
Cryptos are being used in more places by more people all the time, and this massive disruption creates a once-in-a-lifetime opportunity.
A 60% Plunge Doesn’t Make Churchill Capital IV Stock Cheap
Investors clearly misread CCIV stock ahead of its announced merger with Lucid. In that context, the recent sell-off simply makes sense.
Ignore Last Month’s Noise, Alpha Pro Tech Stock Is Heading Lower
What lies ahead? Continued declines back to the single-digits. Perhaps not to its pre-pandemic prices. But still, well below what we see today. So, what's the verdict on APT stock? As was the case last year, stay away.
Why You Should Avoid Pfizer Stock Despite Its Covid-19 Vaccine
While Pfizer has a Covid-19 vaccine out for the public, PFE stock isn't getting much love from Wall Street. Let's avoid it for now.
For Cannabis Investors, Innovative Industrial Properties Has It All
Even after a huge rally, IIPR stock offers a compelling combination of growth and value. It remains one of the best ways to play long-term U.S. cannabis growth.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
